About Us
Editorial Board
Irl B.
Hirsch, MD
Endocrinologist
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition
University of Washington School of Medicine
Dr. Hirsch is a professor of medicine and holds the Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine in Seattle. He graduated from medical school at the University of Missouri, performed his internal medicine training at the University of Miami and Mt. Sinai Medical Center in Miami Beach, and completed his endocrinology fellowship at Washington University in St. Louis.
Dr. Hirsch has been interested in new technologies for the treatment of diabetes, particularly those involved in the use of insulin therapy. He has also been interested in the mechanisms of how insulin co-modulates inflammation with glucose and how this results in improvements in outcomes, particularly of hospitalized patients. The management of hyperglycemia in the hospital has been an interest of Dr. Hirsch for over 25 years. He has been involved in numerous research studies examining novel insulins continuous glucose monitoring, and more recently the artificial pancreas project. He has been involved in many of the key studies that have impacted diabetes treatments today: the DCCT, ACCORD, ADOPT, and ORIGIN. He is currently the co-PI for FLAT-SUGAR..
Dr. Hirsch is also interested in the use of computers in diabetes data management, and how pattern recognition can be used to improve diabetes control, in addition to how glycemic variability noted on glucose meter downloads may be an independent risk for microvascular complications. He has a very active clinical practice of which 80 percent of patients have type 1 diabetes. He has authored over 150 papers including reviews of insulin in the New England Journal of Medicine and JAMA, 40 editorials, numerous book chapters, and four books, written for patients and physicians. He is the past editor-in-chief of both DOC News and Clinical Diabetes, and recently completed his sixth year of the ABIM Subspecialty Board of Endocrinology, Metabolism, and Diabetes.
Dr. Hirsch has been interested in new technologies for the treatment of diabetes, particularly those involved in the use of insulin therapy. He has also been interested in the mechanisms of how insulin co-modulates inflammation with glucose and how this results in improvements in outcomes, particularly of hospitalized patients. The management of hyperglycemia in the hospital has been an interest of Dr. Hirsch for over 25 years. He has been involved in numerous research studies examining novel insulins continuous glucose monitoring, and more recently the artificial pancreas project. He has been involved in many of the key studies that have impacted diabetes treatments today: the DCCT, ACCORD, ADOPT, and ORIGIN. He is currently the co-PI for FLAT-SUGAR..
Dr. Hirsch is also interested in the use of computers in diabetes data management, and how pattern recognition can be used to improve diabetes control, in addition to how glycemic variability noted on glucose meter downloads may be an independent risk for microvascular complications. He has a very active clinical practice of which 80 percent of patients have type 1 diabetes. He has authored over 150 papers including reviews of insulin in the New England Journal of Medicine and JAMA, 40 editorials, numerous book chapters, and four books, written for patients and physicians. He is the past editor-in-chief of both DOC News and Clinical Diabetes, and recently completed his sixth year of the ABIM Subspecialty Board of Endocrinology, Metabolism, and Diabetes.
John L.
Leahy, MD
Endocrinologist
Professor of Medicine
Chief, Endocrinology, Diabetes and Metabolism Unit
University of Vermont College of Medicine
Dr. Leahy is Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Vermont College of Medicine, Burlington. He is Director of the Vermont Regional Diabetes Center and Attending Physician at the Medicine Health Care Service, both at Fletcher Allen Health Care/University of Vermont. Dr. Leahy also serves as Director of the Endocrine Fellowship Program at the university. He is board certified in internal medicine and in endocrinology and metabolism.
After earning his medical degree at the Medical College of Virginia in Richmond, Dr. Leahy completed an internship in medicine at the college. There, he subsequently underwent residency training in medicine, and completed his clinical fellowship in endocrinology and his fellowship in research.
Dr. Leahy’s research interests have included pancreatic beta cell dysfunction and insulin resistance in diabetes, and he is currently the principal investigator in studies examining the mechanisms of beta cell compensation. He also serves as a reviewer for the Metabolism Study Section of the National Institutes of Health. Dr. Leahy has authored and co-authored many book chapters and articles, the latter of which have appeared in such peer-reviewed journals as Diabetes, The Journal of Clinical Investigation, and The New England Journal of Medicine. In addition, he is co-editor of Diabetes, Year Book of Endocrinology, and editor-in-chief of Insulin Therapy and Your Practice: Strategies for Improving Patient Outcomes, published by the American Diabetes Association (ADA).
Dr. Leahy is the recipient of the ADA Mentor Fellowship Award for his work as principal investigator. He is a member of various professional organizations, including the ADA, the Endocrine Society, and the European Association for the Study of Diabetes, among others.
Kevin A.
Peterson, MD, MPH
Family Medicine
Director, Center of Excellence in Primary Care
Professor, University of Minnesota Medical School
Dr. Peterson is a Professor at the University of Minnesota Medical School in the Department of Family Medicine and Community Health where he directs the Center of Excellence in Primary Care. He directs the Minnesota Academy of Family Physicians Research Network (MAFPRN), a primary care Practice-based Research Network (PBRN), and has served as the national director for the AHRQ PBRN Resource Center.
A graduate of Carleton College, Northfield, MN, he received an MD from Mayo Medical School, Rochester, MN and an MPH. from the University of Minnesota. His clinical training includes Johns Hopkins Hospital, Leeds University, England, Rush Presbyterian University, Chicago, and the University of Minnesota (UMN). He is a Fellow of the Royal College of Surgeons in Edinburgh, a Fellow in the American Academy of Family Physicians, and Associate Fellow in the Institute for Health Informatics, UMN.
Dr. Peterson’s research focuses on diabetes, chronic disease management, and informatics in primary care. He has been a principal or site-principal investigator on many National Institutes of Health studies including ACCORD (National Heart Lung and Blood Institute), TRANSLATE (National Institute for Diabetes, Digestive, and Kidney Disease), the creation of a national Electronic Primary Care Research Network (National Center for Research Resources), and studies from the National Cancer Institute, National Institute on Aging, the Agency for Health Research and Quality, and the Center for Disease Control and Prevention.
Doron
Schneider, MD, FACP
General Internist
Chief Patient Safety and Quality Officer
Abington Health
Dr. Schneider practices internal medicine at Abington Memorial Hospital, in Abington, PA. There he serves as Chief Patient Safety and Quality Officer, Deputy Program Director for the Internal Medicine Residency and is a clinic preceptor, hospitalist and teacher.
Dr. Schneider received his medical degree from the University of Medicine and Dentistry of New Jersey (UMDNJ), and completed a residency in internal medicine at New England Deaconess Hospital.
He has published and presented his research in posters, grand rounds, conferences and video. A member of the ACP Diabetes Initiative Advisory Board, Dr. Schneider is also a reviewer for ACP Diabetes Self Assessment Program, ACP Hospitalist and The Journal of Rheumatology. He also serves as national faculty for ACP Quality Net and the ACP Closing the Gap Program. He is a lead physician in the ABIM Maintenance of Certification PIM development program.
Dr. Schneider is a member of the American College of Physicians, the American Medical Association and the Association of Program Directors of Internal Medicine.
Jay
Shubrook, DO, FACOFP, FAAFP
Endocrinologist and Family Physician
Jay Shubrook DO is an Associate Professor of Family Medicine and a Diabetologist at Ohio University Heritage College of Osteopathic Medicine (OUHCOM). He also serves as the Director of the Clinical Division at the Diabetes Institute at Ohio University and the Director of Clinical Research at OUHCOM. He also is the Director of the Diabetes Fellowship. This one year program provides specialty diabetes training for primary care physicians.
He is the former Editor in Chief of the Osteopathic Family Physician (OFP) and serves on the Editorial Advisory Committee for the OFP, American Family Physician, and the Journal of the American Osteopathic Association. He serves on the American Diabetes Association Primary Care Advisory Panel and the Guideline Advantage, a quality collaborative for the American Diabetes Association, American Cancer Society and the American Heart Association.
His research focuses on early interventions in type 2 diabetes and improvements in the quality of care for people with diabetes. He is the principal investigator of the INSPIRE Diabetes study, a trial looking at the use of insulin as the first treatment of type 2 diabetes to preserve beta cell function and provide lasting glucose control in diabetes. He believes that the primary care training that family physicians receive allows them to facilitate chronic disease management by using a patient and family centered approach. With attention to wellness and disease/complication prevention family physicians can have a huge impact on the diabetes epidemic.
He double majored in psychology and psychobiology at the University of California, Santa Cruz and earned his DO at the Ohio University College of Osteopathic Medicine.
